Insider Transactions in Q4 2021 at Uro Gen Pharma Ltd. (URGN)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 30
2021
|
Molly Henderson Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,587
-34.49%
|
$31,044
$12.03 P/Share
|
|
Nov 30
2021
|
Molly Henderson Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+40.0%
|
-
|
|
Nov 30
2021
|
Jason Drew Smith General Counsel |
SELL
Open market or private sale
|
Direct |
3,803
-35.11%
|
$45,636
$12.03 P/Share
|
|
Nov 30
2021
|
Jason Drew Smith General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
8,333
+43.48%
|
-
|
|
Nov 18
2021
|
Mark Schoenberg Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
160
+0.72%
|
$2,080
$13.1 P/Share
|
|
Nov 01
2021
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
258
-1.17%
|
$4,386
$17.16 P/Share
|
|
Oct 31
2021
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+2.21%
|
-
|
|
Oct 27
2021
|
Mark Schoenberg Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
107
-0.49%
|
$1,712
$16.32 P/Share
|
|
Oct 26
2021
|
Mark Schoenberg Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
208
+0.95%
|
-
|